OmniAb to Report Second Quarter 2026 Financial Results on August 6

Thu, 16 Jul 2026 08:00:00 -0400

EMERYVILLE, Calif.--(BUSINESS WIRE)-- OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on Thursday, August 6, 2026, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.

Conference Call and Webcast

What:

OmniAb conference call to discuss second quarter 2026 financial results

OmniAb to Report Second Quarter 2026 Financial Results on August 6

Thu, 16 Jul 2026 08:00:00 -0400

Conference Call and Webcast

What:

OmniAb conference call to discuss second quarter 2026 financial results

OmniAb to Report Second Quarter 2026 Financial Results on August 6

Thu, 16 Jul 2026 08:00:00 -0400

Conference Call and Webcast

What:

OmniAb conference call to discuss second quarter 2026 financial results

OmniAb to Report Second Quarter 2026 Financial Results on August 6

Thu, 16 Jul 2026 08:00:00 -0400

Conference Call and Webcast

What:

OmniAb conference call to discuss second quarter 2026 financial results

Form 3 OmniAb, Inc. For: Jul 13 Filed by: Nwachuku Amechi Ekeke

Mon, 13 Jul 2026 08:08:00 -0400

si-local-file:///var/storage/secattach/20260713/26760176.html

Form 3 OmniAb, Inc. For: Jul 13 Filed by: Nwachuku Amechi Ekeke

Mon, 13 Jul 2026 08:08:00 -0400

si-local-file:///var/storage/secattach/20260713/26760176.html

Form 8-K OmniAb, Inc. For: Jul 13

Mon, 13 Jul 2026 08:07:00 -0400

si-local-file:///var/storage/secattach/20260713/26760173.html

Form 8-K OmniAb, Inc. For: Jul 13

Mon, 13 Jul 2026 08:07:00 -0400

si-local-file:///var/storage/secattach/20260713/26760173.html

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

Nwachuku brings more than 25 years of experience in life sciences. He most recently served as Vice President of Global Commercial Genetic Sciences at Thermo Fisher Scientific, and previously as Senior Vice President of Global Commercial at SCIEX, a Danaher Corporation unit. He also held senior roles at Beckman Coulter Diagnostics, Johnson & Johnson Diabetes

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

OmniAb names Amechi Nwachuku as chief operating officer

Mon, 13 Jul 2026 08:00:47 -0400

OmniAb, Inc. (NASDAQ: OABI) has appointed Amechi Nwachuku to the newly created position of Executive Vice President and Chief Operating Officer, according to a company press release.

Nwachuku will be primarily responsible for managing the strategy, operations and commercial development of xPloration, OmniAb's single B-cell screening platform.

OmniAb Names Amechi Nwachuku Chief Operating Officer